Celsion Corp

NASDAQ:CLSN   3:54:00 PM EDT
0.95
0.00 (+0.16%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)82.36M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.13 Million
Adjusted EPS-$0.11
See more estimates
10-Day MA$0.97
50-Day MA$1.00
200-Day MA$1.30
See more pivots

Celsion Corp Stock, NASDAQ:CLSN

997 Lenox Drive, Suite 100, Lawrenceville, New Jersey 08648
United States of America
Phone: +1.609.896.9100
Number of Employees: 27

Description

Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.